Update on feline asthma

Veterinary Clinics of North America - Small Animal Practice

Volumn 44, Issue 1, 2014, Pages 91-105

  Trzil, Julie E ^a   Reinero, Carol R ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Airway eosinophilia; Airway hyperresponsiveness; Feline asthma; Feline lower airway disease

Indexed keywords

BRONCHODILATING AGENT; CETIRIZINE; CYPROHEPTADINE; FLUNISOLIDE; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; GLUCOCORTICOID; LIDOCAINE; LUTEOLIN; MASITINIB; OMEGA 3 FATTY ACID; PREDNISOLONE; PREDNISONE; PROTEIN TYROSINE KINASE INHIBITOR; SALMETEROL; ZAFIRLUKAST;

AELUROSTRONGYLOSIS; ALLERGY TEST; ANIMAL PARASITOSIS; BRONCHOSCOPY; CAT DISEASE; CHRONIC BRONCHITIS; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DIROFILARIASIS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MONITORING; FELINE ASTHMA; IMMUNOTHERAPY; LOW DRUG DOSE; LUNG FUNCTION TEST; LUNG LAVAGE; NONHUMAN; PATHOGENESIS; PHYSICAL EXAMINATION; RESPIRATORY TRACT INFECTION; REVIEW; STEM CELL TRANSPLANTATION; THORAX RADIOGRAPHY; TOXOCARIASIS; AIRWAY EOSINOPHILIA; ANIMAL; ANIMAL DISEASE; ASTHMA; CAT; FELINE LOWER AIRWAY DISEASE; PATHOLOGY; RESPIRATORY TRACT ALLERGY;

FELIDAE;

AIRWAY EOSINOPHILIA; AIRWAY HYPERRESPONSIVENESS; FELINE ASTHMA; FELINE LOWER AIRWAY DISEASE;

ANIMALS; ASTHMA; CAT DISEASES; CATS;

EID: 84888197254     PISSN: 01955616     EISSN: 18781306     Source Type: Journal    
DOI: 10.1016/j.cvsm.2013.08.006     Document Type: Review

References (86)

1. Reinero C.R. Advances in the understanding of pathogenesis, and diagnostics and therapeutics for feline allergic asthma. Vet J 2011, 190(1):28-33.
2. Padrid P. Chronic bronchitis and asthma in cats. Current veterinary therapy XIV 2009, 650-658. WB Saunders, Philadelphia. J. Bonagura, D. Twedt (Eds.).
3. Adamama-Moraitou K.K., Patsikas M.N., Koutinas A.F. Feline lower airway disease: a retrospective study of 22 naturally occurring cases from Greece. JFeline Med Surg 2004, 6(4):227-233.
4. Corcoran B.M., Foster D.J., Fuentes V.L. Feline asthma syndrome: a retrospective study of the clinical presentation in 29 cats. JSmall Anim Pract 1995, 36(11):481-488.
5. Dye J.A., McKiernan B.C., Rozanski E.A., et al. Bronchopulmonary disease in the cat: historical, physical, radiographic, clinicopathologic, and pulmonary functional evaluation of 24 affected and 15 healthy cats. JVet Intern Med 1996, 10(6):385-400.
6. Foster S.F., Allan G.S., Martin P., et al. Twenty-five cases of feline bronchial disease (1995-2000). JFeline Med Surg 2004, 6(3):181-188.
7. Moise N.S., Wiedenkeller D., Yeager A.E., et al. Clinical, radiographic, and bronchial cytologic features of cats with bronchial disease: 65 cases (1980-1986). JAm Vet Med Assoc 1989, 194(10):1467-1473.
8. Busse W, Camargo C Jr, Boushey H, etal. Expert panel report 3: guidelines for the diagnosis and management of asthma. 2007. Available at: Accessed June 24, 2013. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm.
9. Nafe L.A., DeClue A.E., Lee-Fowler T.M., et al. Evaluation of biomarkers in bronchoalveolar lavage fluid for discrimination between asthma and chronic bronchitis in cats. Am J Vet Res 2010, 71(5):583-591.
10. Lacorcia L., Gasser R.B., Anderson G.A., et al. Comparison of bronchoalveolar lavage fluid examination and other diagnostic techniques with the Baermann technique for detection of naturally occurring Aelurostrongylus abstrusus infection in cats. JAm Vet Med Assoc 2009, 235(1):43-49.
11. Dillon A.R., Blagburn B., Tillson D., et al. Immature heartworm infection produces pulmonary parenchymal, airway, and vascular disease in cats. JVet Intern Med 2007, 21(3):608-609. [abstract].
12. Lee A.C., Atkins C.E. Understanding feline heartworm infection: disease, diagnosis, and treatment. Top Companion Anim Med 2010, 25(4):224-230.
13. Garcia-Guasch L., Caro-Vadillo A., Manubens-Grau J., et al. Is Wolbachia participating in the bronchial reactivity of cats with heartworm associated respiratory disease?. Vet Parasitol 2013, 196(1-2):130-135.
14. Sprent J.F. The life history and development of Toxocara cati (Schrank 1788) in the domestic cat. Parasitology 1956, 46(1-2):54-78.
15. Swerczek T.W., Nielsen S.W., Helmboldt C.F. Ascariasis causing pulmonary arterial hyperplasia in cats. Res Vet Sci 1970, 11(1):103-104.
16. Dillon A.R., Tillson D.M., Hathcock J., et al. Lung histopathology, radiography, high-resolution computed tomography, and bronchio-alveolar lavage cytology are altered by Toxocara cati infection in cats and is independent of development of adult intestinal parasites. Vet Parasitol 2013, 193(4):413-426.
17. Niimi A., Matsumoto H., Amitani R., et al. Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices. Am J Respir Crit Care Med 2000, 162(4 Pt 1):1518-1523.
18. Niimi A., Matsumoto H., Takemura M., et al. Clinical assessment of airway remodeling in asthma: utility of computed tomography. Clin Rev Allergy Immunol 2004, 27(1):45-58.
19. Mitsunobu F., Tanizaki Y. The use of computed tomography to assess asthma severity. Curr Opin Allergy Clin Immunol 2005, 5(1):85-90.
20. Oliveira C.R., Mitchell M.A., O'Brien R.T. Thoracic computed tomography in feline patients without use of chemical restraint. Vet Radiol Ultrasound 2011, 52(4):368-376.
21. Oliveira C.R., Ranallo F.N., Pijanowski G.J., et al. The VetMousetrap: a device for computed tomographic imaging of the thorax of awake cats. Vet Radiol Ultrasound 2011, 52(1):41-52.
22. Masseau I., Chang C., LeFloch M., et al. Assessment of airway hyperresponsiveness in tandem with remodeling using pulmonary mechanics and computed tomography in experimental feline asthma. JVet Intern Med 2013, 27(3):754. [abstract R-3].
23. Johnson L.R., Vernau W. Bronchoscopic findings in 48 cats with spontaneous lower respiratory tract disease (2002-2009). JVet Intern Med 2011, 25(2):236-243.
24. Hawkins E.C., DeNicola D.B., Kuehn N.F. Bronchoalveolar lavage in the evaluation of pulmonary disease in the dog and cat. State of the art. JVet Intern Med 1990, 4(5):267-274.
25. McCarthy G.M., Quinn P.J. Bronchoalveolar lavage in the cat: cytological findings. Can J Vet Res 1989, 53(3):259-263.
26. McCarthy G.M., Quinn P.J. Age-related changes in protein concentrations in serum and respiratory tract lavage fluid obtained from cats. Am J Vet Res 1991, 52(2):254-260.
27. Padrid P.A., Feldman B.F., Funk K., et al. Cytologic, microbiologic, and biochemical analysis of bronchoalveolar lavage fluid obtained from 24 healthy cats. Am J Vet Res 1991, 52(8):1300-1307.
28. Laprise C., Laviolette M., Boutet M., et al. Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling. Eur Respir J 1999, 14(1):63-73.
29. Obase Y., Shimoda T., Kawano T., et al. Bronchial hyperresponsiveness and airway inflammation in adolescents with asymptomatic childhood asthma. Allergy 2003, 58(3):213-220.
30. Cocayne C.G., Reinero C.R., DeClue A.E. Subclinical airway inflammation despite high-dose oral corticosteroid therapy in cats with lower airway disease. JFeline Med Surg 2011, 13(8):558-563.
31. Foster S.F., Martin P., Braddock J.A., et al. Aretrospective analysis of feline bronchoalveolar lavage cytology and microbiology (1995-2000). JFeline Med Surg 2004, 6(3):189-198.
32. Lee-Fowler T.M., Guntur V., Dodam J., et al. The tyrosine kinase inhibitor masitinib blunts airway inflammation and improves associated lung mechanics in a feline model of chronic allergic asthma. Int Arch Allergy Immunol 2012, 158(4):369-374.
33. Bark H., Epstein A., Bar-Yishay E., et al. Non-invasive forced expiratory flow-volume curves to measure lung function in cats. Respir Physiol Neurobiol 2007, 155(1):49-54.
34. Hoffman A.M., Dhupa N., Cimetti L. Airway reactivity measured by barometric whole-body plethysmography in healthy cats. Am J Vet Res 1999, 60(12):1487-1492.
35. Kirschvink N., Leemans J., Delvaux F., et al. Non-invasive assessment of airway responsiveness in healthy and allergen-sensitised cats by use of barometric whole body plethysmography. Vet J 2007, 173(2):343-352.
36. McKiernan B.C., Johnson L.R. Clinical pulmonary function testing in dogs and cats. Vet Clin North Am Small Anim Pract 1992, 22(5):1087-1099.
37. Hirt R.A., Galler A., Shibly S., et al. Airway hyperresponsiveness to adenosine 5'-monophosphate in feline chronic inflammatory lower airway disease. Vet J 2011, 187(1):54-59.
38. Bates J., Irvin C., Brusasco V., et al. The use and misuse of Penh in animal models of lung disease. Am J Respir Cell Mol Biol 2004, 31(3):373-374.
39. Allerton F.J., Leemans J., Tual C., et al. Correlation of bronchoalveolar eosinophilic percentage with airway responsiveness in cats with chronic bronchial disease. JSmall Anim Pract 2013, 54(5):258-264.
40. Reinero C.R., Lee-Fowler T.M., Dodam J.R., et al. Endotracheal nebulization of N-acetylcysteine increases airway resistance in cats with experimental asthma. JFeline Med Surg 2011, 13(2):69-73.
41. Chang C.H., Dodam J.R., Cohn L.A., et al. Validation of direct and indirect bronchoprovocation testing using ventilator-acquired pulmonary mechanics in healthy and experimentally asthmatic cats. JVet Intern Med 2013, 27(3):753. [abstract R-5].
42. Reinero C.R., Decile K.C., Byerly J.R., et al. Effects of drug treatment on inflammation and hyperreactivity of airways and on immune variables in cats with experimentally induced asthma. Am J Vet Res 2005, 66(7):1121-1127.
43. Leemans J., Kirschvink N., Clercx C., et al. Effect of short-term oral and inhaled corticosteroids on airway inflammation and responsiveness in a feline acute asthma model. Vet J 2012, 192(1):41-48.
44. Leemans J., Kirschvink N., Bernaerts F., et al. Salmeterol or doxycycline do not inhibit acute bronchospasm and airway inflammation in cats with experimentally-induced asthma. Vet J 2012, 192(1):49-56.
45. Cohn L.A., DeClue A.E., Cohen R.L., et al. Effects of fluticasone propionate dosage in an experimental model of feline asthma. JFeline Med Surg 2010, 12(2):91-96.
46. Leemans J., Kirschvink N., Gustin P. Acomparison of invitro relaxant responses to ipratropium bromide, beta-adrenoceptor agonists and theophylline in feline bronchial smooth muscle. Vet J 2012, 193(1):228-233.
47. Stursberg U., Zenker I., Hecht S., et al. Use of propentofylline in feline bronchial disease: prospective, randomized, positive-controlled study. JAm Anim Hosp Assoc 2010, 46(5):318-326.
48. Leemans J., Kirschvink N., Bernaerts F., et al. Apilot study comparing the antispasmodic effects of inhaled salmeterol, salbutamol and ipratropium bromide using different aerosol devices on muscarinic bronchoconstriction in healthy cats. Vet J 2009, 180(2):236-245.
49. Leemans J., Kirschvink N., Clercx C., et al. Functional response to inhaled salbutamol and/or ipratropium bromide in Ascaris suum-sensitised cats with allergen-induced bronchospasms. Vet J 2010, 186(1):76-83.
50. Rozanski E.A., Hoffman A.M. Pulmonary function testing in small animals. Clin Tech Small Anim Pract 1999, 14(4):237-241.
51. Spitzer W.O., Suissa S., Ernst P., et al. The use of beta-agonists and the risk of death and near death from asthma. NEngl J Med 1992, 326(8):501-506.
52. Reinero C.R., Delgado C., Spinka C., et al. Enantiomer-specific effects of albuterol on airway inflammation in healthy and asthmatic cats. Int Arch Allergy Immunol 2009, 150(1):43-50.
53. Dhand R., Goode M., Reid R., et al. Preferential pulmonary retention of (S)-albuterol after inhalation of racemic albuterol. Am J Respir Crit Care Med 1999, 160(4):1136-1141.
54. Lee-Fowler T.M., Cohn L.A., DeClue A.E., et al. Evaluation of subcutaneous versus mucosal (intranasal) allergen-specific rush immunotherapy in experimental feline asthma. Vet Immunol Immunopathol 2009, 129(1-2):49-56.
55. Reinero C.R., Byerly J.R., Berghaus R.D., et al. Rush immunotherapy in an experimental model of feline allergic asthma. Vet Immunol Immunopathol 2006, 110(1-2):141-153.
56. Reinero C.R., Cohn L.A., Delgado C., et al. Adjuvanted rush immunotherapy using CpG oligodeoxynucleotides in experimental feline allergic asthma. Vet Immunol Immunopathol 2008, 121(3-4):241-250.
57. Lee-Fowler T.M., Cohn L.A., DeClue A.E., et al. Comparison of intradermal skin testing (IDST) and serum allergen-specific IgE determination in an experimental model of feline asthma. Vet Immunol Immunopathol 2009, 132(1):46-52.
58. Reinero C., Lee-Fowler T., Chang C.H., et al. Beneficial cross-protection of allergen-specific immunotherapy on airway eosinophilia using unrelated or a partial repertoire of allergen(s) implicated in experimental feline asthma. Vet J 2012, 192(3):412-416.
59. Calder P.C. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids 2006, 75(3):197-202.
60. Leemans J., Cambier C., Chandler T., et al. Prophylactic effects of omega-3 polyunsaturated fatty acids and luteolin on airway hyperresponsiveness and inflammation in cats with experimentally-induced asthma. Vet J 2010, 184(1):111-114.
61. Decco M.L., Neeno T.A., Hunt L.W., et al. Nebulized lidocaine in the treatment of severe asthma in children: a pilot study. Ann Allergy Asthma Immunol 1999, 82(1):29-32.
62. Hunt L.W., Frigas E., Butterfield J.H., et al. Treatment of asthma with nebulized lidocaine: a randomized, placebo-controlled study. JAllergy Clin Immunol 2004, 113(5):853-859.
63. Hunt L.W., Swedlund H.A., Gleich G.J. Effect of nebulized lidocaine on severe glucocorticoid-dependent asthma. Mayo Clin Proc 1996, 71(4):361-368.
64. Nafe L.A., Guntur V.P., Dodam J.R., et al. Nebulized lidocaine blunts airway hyper-responsiveness in experimental feline asthma. JFeline Med Surg 2013, 15(8):712-716.
65. Guntur V.P., Reinero C.R. The potential use of tyrosine kinase inhibitors in severe asthma. Curr Opin Allergy Clin Immunol 2012, 12(1):68-75.
66. Chang CH, Dodam JR, Cohn LA, etal. An experimental janus kinase (JAK) inhibitor suppressess eosinophilic airway inflammation in feline asthma. In: ACVIM Forum Proceedings. 2013. Available at: Accessed June 24, 2013. http://www.vin.com/Members/Proceedings/Proceedings.plx?CID=ACVIM2013%26Category=%26PID=89227%26O=Generic.
67. Bonfield T.L., Koloze M., Lennon D.P., et al. Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol Lung Cell Mol Physiol 2010, 299(6):L760-L770.
68. Firinci F., Karaman M., Baran Y., et al. Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma. Int Immunopharmacol 2011, 11(8):1120-1126.
69. Goodwin M., Sueblinvong V., Eisenhauer P., et al. Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice. Stem Cells 2011, 29(7):1137-1148.
70. Ou-Yang H.F., Huang Y., Hu X.B., et al. Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells. Exp Biol Med (Maywood) 2011, 236(12):1461-1467.
71. Masseau I, Trzil JE, Chang CH, etal. Stem cell therapy blunts computed tomographic measures of airway remodeling in experimental feline asthma. In: ACVIM Forum Proceedings. 2013. Available at: Accessed June 24, 2013. http://www.vin.com/Members/Proceedings/Proceedings.plx?CID=ACVIM2013%26Category=%26PID=89242%26O=Generic.
72. Norris C.R., Decile K.C., Berghaus L.J., et al. Concentrations of cysteinyl leukotrienes in urine and bronchoalveolar lavage fluid of cats with experimentally induced asthma. Am J Vet Res 2003, 64(11):1449-1453.
73. Padrid P.A., Mitchell R.W., Ndukwu I.M., et al. Cyproheptadine-induced attenuation of type-I immediate-hypersensitivity reactions of airway smooth muscle from immune-sensitized cats. Am J Vet Res 1995, 56(1):109-115.
74. Mitchell R.W., Cozzi P., Ndukwu I.M., et al. Differential effects of cyclosporine A after acute antigen challenge in sensitized cats invivo and exvivo. Br J Pharmacol 1998, 123(6):1198-1204.
75. Schooley E.K., McGee Turner J.B., Jiji R.D., et al. Effects of cyproheptadine and cetirizine on eosinophilic airway inflammation in cats with experimentally induced asthma. Am J Vet Res 2007, 68(11):1265-1271.
76. Norris C.R., Boothe D.M., Esparza T., et al. Disposition of cyproheptadine in cats after intravenous or oral administration of a single dose. Am J Vet Res 1998, 59(1):79-81.
77. Banovcin P., Visnovsky P., Korpas J. Pharmacological analysis of reactivity changes in airways due to acute inflammation in cats. Acta Physiol Hung 1987, 70(2-3):181-187.
78. Barnes P.J. Histamine and serotonin. Pulm Pharmacol Ther 2001, 14(5):329-339.
79. Wenzel S.E., Fowler A.A., Schwartz L.B. Activation of pulmonary mast cells by bronchoalveolar allergen challenge. Invivo release of histamine and tryptase in atopic subjects with and without asthma. Am Rev Respir Dis 1988, 137(5):1002-1008.
80. Wilson A.M. The role of antihistamines in asthma management. Treat Respir Med 2006, 5(3):149-158.
81. Dery R.E., Ulanova M., Puttagunta L., et al. Frontline: inhibition of allergen-induced pulmonary inflammation by the tripeptide feG: a mimetic of a neuro-endocrine pathway. Eur J Immunol 2004, 34(12):3315-3325.
82. Dery R.E., Mathison R., Davison J., et al. Inhibition of allergic inflammation by C-terminal peptides of the prohormone submandibular rat 1 (SMR-1). Int Arch Allergy Immunol 2001, 124(1-3):201-204.
83. Eberhardt J.M., DeClue A.E., Reinero C.R. Chronic use of the immunomodulating tripeptide feG-COOH in experimental feline asthma. Vet Immunol Immunopathol 2009, 132(2-4):175-180.
84. Norris Reinero C.R., Decile K.C., Berghaus R.D., et al. An experimental model of allergic asthma in cats sensitized to house dust mite or bermuda grass allergen. Int Arch Allergy Immunol 2004, 135(2):117-131.
85. Padrid P. Feline asthma. Diagnosis and treatment. Vet Clin North Am Small Anim Pract 2000, 30(6):1279-1293.
86. Padrid P., Snook S., Finucane T., et al. Persistent airway hyperresponsiveness and histologic alterations after chronic antigen challenge in cats. Am J Respir Crit Care Med 1995, 151(1):184-193.